Policy Seminar
The Policy Seminar is held once a year as an activity to strengthen understanding and support for the current situation and issues surrounding the JPMA industry, as well as to promote the JPMA's advocacy.
- *(Affiliations and positions are as of the time of the seminar)
-
Policy Seminar
Prospects of Next Generation Medical Care Pioneered by DX - New Challenges for Medical DX that Transcends Industries, Driven by Co-Creation
Akihisa Shiozaki, Member of the House of Representatives
Mr. Taiki Makiguchi, Chief Technology Officer, Zeureka
Mr. Shinji Senzaki, Director and Leader of Healthcare & Life Sciences, IBM Japan
Mr. Jun Ando, Editorial Writer, Nikkei Inc.
Ms Asuka Miyabashira, Chairperson, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
Aiming to Improve Japan's Drug Discovery Capability: What Value Innovative New Drugs Bring to Society
Tsutomu Takeuchi, President, Saitama Medical University / Professor Emeritus, Keio University
Professor Yasufumi Okuno, Department of Big Data Medical Science, Graduate School of Medicine, Kyoto University
Professor, Kyoto University iPS Cell Research Institute; Professor, Faculty of Medicine and Medical Sciences, University of Tsukuba; Co-founder, Shinobi Therapeutics, Arata Kaneko
Shinsuke Muto, Chairman and CEO of Integrity Healthcare / President and CEO of DCT Japan
Hiroyuki Kakinoki, Director of DCT Japan
Atsushi Ando, Editorial Writer, The Nikkei
Hiroaki Ueno, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
Toward a Nation Driven by Innovation: Strengthening Japan's Drug Discovery Capabilities and Universal Health Coverage
Mr. Norihisa Tamura, Member of the House of Representatives, Acting Chair of the Policy Research Council of the Liberal Democratic Party / Former Minister of Health, Labor and Welfare
Mr. Teruyuki Katori, Representative Director, General Incorporated Association Future Research Institute Garryu / Specially Appointed Professor, Graduate School of Social Sciences, Hyogo Prefectural University
Mr. Shinsuke Amano, Chairman, National Federation of Cancer Patient Organizations
Ms. Chizuko Koseki, Representative Director, Tagix Bio, Inc.
Mr. Hiroaki Ueno, Chairperson, Japan Pharmaceutical Manufacturers Association
Mr. Jun Ando, Editorial Writer, The Nikkei -
Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation
Akira Amari, Member of the House of Representatives, Liberal Democratic Party, Chair of the Economic Security Measures Headquarters
Nao Yoshizawa, Managing Attorney, GRiT Partners Law Firm / Expert Advisor on Bio Strategy, Cabinet Office
BT Slingsby, Founder & Managing Partner, Catalys Pacific
Serial Entrepreneur / Director and Co-Founder of Fenixi: Ms. Yuko Kunou
President and CEO of Modalis: Mr. Haruhiko Morita
President and CEO of KSP / Founder of PeptideDream: Mr. Kiichi Kubota
Tomoyoshi Koyanagi, Professor, Faculty of Medicine and Medical Sciences, University of Tsukuba / Director, TR Promotion and Education Center, Tsukuba Clinical Medicine Research and Development Organization
Kozo Saeki, Director, Biochemical Industry Division, Commerce and Services Group, Ministry of Economy, Trade and Industry
Yasushi Okada, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration?
University of Tsukuba Graduate School, Doctoral Program / Google and Microsoft Research Ph.D. Fellow: Mr. Hiromu Yagura
Professor, Graduate School of Science and Technology Innovation, Kobe University / Representative Director, President, and CEO of Simprogen (concurrent position), Kazuhiko Yamamoto
Executive Officer and Vice President, The University of Tokyo / Professor, Center for Future Vision Research, The University of Tokyo, Toshiya Watanabe
Professor, Faculty of Science and Engineering, Waseda University / Chairman, DEN Mii Clinic Medical Corporation: Toshio Miyata
Deputy Director-General for Commerce and Services, Ministry of Economy, Trade and Industry: Tadashi Mogi
President and CEO, MTI: Toshihiro Maeda
Chairman, Japan Pharmaceutical Manufacturers Association: Yasushi Okada -
Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era
Mr. Koichi Tanaka, Executive Research Fellow, Shimadzu Corporation / Director, Koichi Tanaka Memorial Mass Spectrometry Research Institute
Mr. Hiroyuki Manno, Executive Director, National Cancer Center Research Institute / Director, National Cancer Center Research Institute / Director, Cancer Genome Information Management Center
Mr. Masayuki Yamamoto, Director, Tohoku Medical Megabank Organization, Tohoku University
Ms. Tamayo Marukawa, Member of the House of Councillors
Mr. Yasumasa Fukushima, Director-General for Medical Affairs, Ministry of Health, Labor and Welfare
Ms. Naomi Sakurai, President and CEO, Cancer Solutions
Mr. Joji Nakayama, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
What can be achieved through innovation in pharmaceuticals - Contribution of new drugs, expectations and future challenges
Tadaharu Goto, Chairman, Japan Pharmaceutical Manufacturers Association
Shinzo Abe, Prime Minister of Japan
Seiichi Eto, Senior Advisor to the Prime Minister
Yasuhiro Suzuki, Director-General for Medical Affairs, Ministry of Health, Labor and Welfare
Princess Dina Milad of the Hashemite Kingdom of Jordan / President, Union for International Cancer Control
Professor (Special Appointment), Global Research Institute, Keio University / Chairman, Global Health Technology Promotion Foundation
Nobel Laureate in Physiology or Medicine / Professor Emeritus, Kitasato University: Satoshi Omura
Deputy Director, Health and Medical Strategy Office, Cabinet Secretariat: Hiroko Otsubo
Mr. Hiroyuki Manno, Executive Director and Institute Director, National Cancer Center; Director, Cancer Genome Information Management Center
Mr. Yoshiyuki Mashima, Chairman, PanCAN Japan (Specified Nonprofit Corporation)
Mr. Joji Nakayama, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
The Turning Point in Healthcare and the Pharmaceutical Industry: Promoting the Utilization of Medical Big Data
Japan Pharmaceutical Manufacturers Association: Tadaharu Goto, Chairman
Kyoto University and Miyazaki University: Hiroyuki Yoshihara, Professor Emeritus
National Cancer Center East Hospital: Atsushi Otsu, Hospital Director
Mr. Toshihisa Okamoto, Counselor, Health and Medical Strategy Office, Cabinet Secretariat
Mr. Yoshihiko Hatanaka, Chairman, Japan Pharmaceutical Manufacturers Association
Mr. Hiroaki Miyata, Professor, Department of Health Policy and Management, Keio University School of Medicine -
Policy Seminar
Drug Discovery Innovation and the Future of the Pharmaceutical Industry
Tadaharu Goto, Chairman, Japan Pharmaceutical Manufacturers Association
Makoto Suematsu, President, Japan Agency for Medical Research and Development (AMED)
Ms. Keiko Morimitsu, Director, Research and Development Promotion Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
Mr. Keita Mori, President and CEO, SanBio, Inc.
Mr. Yoshihiko Hatanaka, Chairman, Japan Pharmaceutical Manufacturers Association
Professor Hiroaki Miyata, Department of Health Policy and Management, School of Medicine, Keio University -
Policy Seminar
Questioning the Value of Pharmaceuticals - Considering the Evaluation of Innovation in the National Health Insurance System
Tadaharu Goto, Chairman, Japan Pharmaceutical Manufacturers Association
Mr. Sadao Nagaoka, Professor, Faculty of Economics, Tokyo Keizai University
Mr. Tomohiro Onishi, Director of the Economic Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
Professor Hisao Endo, Faculty of Economics, Gakushuin University
Chairman Yoshihiko Hatanaka, Japan Pharmaceutical Manufacturers Association
Senior Advisor Mase Mita, Investment Banking Division, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.